EnsoData logo β€” Empowering clinicians with #waveformAI 🍍

EnsoData

Empowering clinicians with #waveformAI 🍍

Founded 2015 United States Madison, United States 57 employees Series A Total: $31.05M AI, Analytics +2

General Information

Company Name EnsoData
Founded Year 2015
Location United States Madison, United States
Employees 57
Industries AI, Analytics, Health Care +1
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with EnsoData. To contact EnsoData, visit ensodata.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does EnsoData compare?

A PDF of EnsoData and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting EnsoData soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About EnsoData

EnsoData is an AI and Machine Learning startup empowering clinicians with #waveformAI 🍍. Leveraging Artificial Intelligence (AI), the company aims to facilitate rapid, accurate, and affordable diagnoses for major health threats. Over the past eight years, EnsoData has been at the forefront of applying AI and ML to healthcare, particularly in sleep medicine, to address critical issues in diagnosis and treatment decision-making. The company's FDA-cleared solution, EnsoSleep, provides diagnostic analysis of in-lab sleep studies and was expanded in 2021 to include home sleep studies, a viewing and reporting platform, and total sleep time measurement. The recent FDA clearance for the EnsoSleep PPG algorithm in February 2024 further demonstrates EnsoData's commitment to innovation. This new algorithm harnesses wearable FDA-cleared pulse oximetry technology as a diagnostic tool, offering a more cost-effective and accessible solution for clinicians. The $20.00M Series A investment received in April 2022 from Colle Capital, M25, Zetta Venture Partners, HealthX Ventures, Supermoon Capital, Venture Investors, Justin Mortara, Inspire Medical Systems, and Frederick Robertson underscores the investor confidence in EnsoData's potential to enhance healthcare turnaround times, address patient backlogs, and improve overall patient care and health outcomes. Based in the United States, EnsoData continues to pave the way for advancements in AI and Analytics within the healthcare industry.

Business keywords: FDA Clearance, Clinical Diagnosis, Sleep Medicine, Healthcare Solutions, Pulse Oximetry, Diagnostic Tools, Medical Device Innovation

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $20.00M 9
Colle Capital, M25 +7
27 Apr 2022
Series A $9.00M 10
Colle Capital, Zetta Venture Partners +8
10 Jun 2020
Seed Round $1.50M 5
Colle Capital, M25 +3
02 Mar 2018
Non Equity Assistance Undisclosed 1
Healthbox
12 Sep 2017
Seed Round $550.00K 1
HealthX Ventures
13 Apr 2016
Non Equity Assistance Undisclosed 1
gbeta
01 Jun 2015

EnsoData Alternatives & Competitors

View All Alternatives
EnsoData vs
Qure.ai
Qure.ai United States

Our mission is to make healthcare more affordable and accessible through the power of Artificial Int...

Series D
367 employees
AI, Health Care
EnsoData vs
Elaitra
Elaitra United Kingdom

Improving breast cancer detection with state-of-the-art neural networks.

Pre-Seed
6 employees
AI, Health Care
EnsoData vs
Casana
Casana United States

Meet the future of in-home health monitoring, where you’d least expect it.

Series B
48 employees
AI, Health Care

FAQ About EnsoData

Empowering clinicians with #waveformAI 🍍
EnsoData was founded in 2015.
EnsoData is headquartered in Madison, United States.
EnsoData operates in AI, Analytics, Health Care and Machine Learning. Its work centres on FDA Clearance, Clinical Diagnosis, Sleep Medicine and Healthcare Solutions.
EnsoData has approximately 57 employees.
EnsoData has completed 6 funding rounds, raising a total of $31.05M. The latest funding stage is Series A.
Top alternatives and competitors to EnsoData include Qure.ai, Elaitra, Casana, Altris AI, Ziosoft. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
EnsoData and Qure.ai are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for EnsoData, https://bouncewatch.com/company/ensodata, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes